Rachael L Morton1, Angela C Webster2, Kevin McGeechan2, Kirsten Howard2, Fliss E M Murtagh3, Nicholas A Gray4, Peter G Kerr5, Michael J Germain6, Paul Snelling7. 1. National Health and Medical Research Council Clinical Trials Centre, Sydney Medical School and rachael.morton@ctc.usyd.edu.au. 2. Sydney School of Public Health, The University of Sydney, Camperdown, New South Wales, Australia. 3. Cicely Saunders Institute, King's College London, Denmark Hill, United Kingdom. 4. Sunshine Coast Clinical School, The University of Queensland and Renal Unit, Nambour General Hospital, Nambour, Australia. 5. Department of Nephrology, Monash Medical Centre, Clayton, Australia. 6. Department of Medicine, Division of Nephology, Baystate Medical Center, Springfield, Massachusetts; and. 7. Department of Renal Medicine Royal Prince Alfred Hospital, Camperdown, Australia.
Abstract
BACKGROUND AND OBJECTIVES: We aimed to determine the proportion of patients who switched to dialysis after confirmed plans for conservative care and compare survival and end-of-life care among patients choosing conservative care with those initiating RRT. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A cohort study of 721 patients on incident dialysis, patients receiving transplants, and conservatively managed patients from 66 Australian renal units entered into the Patient Information about Options for Treatment Study from July 1 to September 30, 2009 were followed for 3 years. A two-sided binomial test assessed the proportion of patients who switched from conservative care to RRT. Cox regression, stratified by center and adjusted for patient and treatment characteristics, estimated factors associated with 3-year survival. RESULTS: In total, 102 of 721 patients planned for conservative care, and median age was 80 years old. Of these, 8% (95% confidence interval, 3% to 13%), switched to dialysis, predominantly for symptom management. Of 94 patients remaining on a conservative pathway, 18% were alive at 3 years. Of the total 721 patients, 247 (34%) died by study end. In multivariable analysis, factors associated with all-cause mortality included older age (hazard ratio, 1.55; 95% confidence interval, 1.36 to 1.77), baseline serum albumin <3.0 versus 3.7-5.4 g/dl (hazard ratio, 4.31; 95% confidence interval, 2.72 to 6.81), and management with conservative care compared with RRT (hazard ratio, 2.18; 95% confidence interval, 1.39 to 3.40). Of 247 deaths, patients managed with RRT were less likely to receive specialist palliative care (26% versus 57%; P<0.001), more likely to die in the hospital (66% versus 42%; P<0.001) than home or hospice, and more likely to receive palliative care only within the last week of life (42% versus 15%; P<0.001) than those managed conservatively. CONCLUSIONS: Survival after 3 years of conservative management is common, with relatively few patients switching to dialysis. Specialist palliative care services are used more frequently and at an earlier time point for conservatively managed patients, a practice associated with better symptom management and quality of life.
BACKGROUND AND OBJECTIVES: We aimed to determine the proportion of patients who switched to dialysis after confirmed plans for conservative care and compare survival and end-of-life care among patients choosing conservative care with those initiating RRT. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A cohort study of 721 patients on incident dialysis, patients receiving transplants, and conservatively managed patients from 66 Australian renal units entered into the Patient Information about Options for Treatment Study from July 1 to September 30, 2009 were followed for 3 years. A two-sided binomial test assessed the proportion of patients who switched from conservative care to RRT. Cox regression, stratified by center and adjusted for patient and treatment characteristics, estimated factors associated with 3-year survival. RESULTS: In total, 102 of 721 patients planned for conservative care, and median age was 80 years old. Of these, 8% (95% confidence interval, 3% to 13%), switched to dialysis, predominantly for symptom management. Of 94 patients remaining on a conservative pathway, 18% were alive at 3 years. Of the total 721 patients, 247 (34%) died by study end. In multivariable analysis, factors associated with all-cause mortality included older age (hazard ratio, 1.55; 95% confidence interval, 1.36 to 1.77), baseline serum albumin <3.0 versus 3.7-5.4 g/dl (hazard ratio, 4.31; 95% confidence interval, 2.72 to 6.81), and management with conservative care compared with RRT (hazard ratio, 2.18; 95% confidence interval, 1.39 to 3.40). Of 247 deaths, patients managed with RRT were less likely to receive specialist palliative care (26% versus 57%; P<0.001), more likely to die in the hospital (66% versus 42%; P<0.001) than home or hospice, and more likely to receive palliative care only within the last week of life (42% versus 15%; P<0.001) than those managed conservatively. CONCLUSIONS: Survival after 3 years of conservative management is common, with relatively few patients switching to dialysis. Specialist palliative care services are used more frequently and at an earlier time point for conservatively managed patients, a practice associated with better symptom management and quality of life.
Authors: Sara N Davison; Adeera Levin; Alvin H Moss; Vivekanand Jha; Edwina A Brown; Frank Brennan; Fliss E M Murtagh; Saraladevi Naicker; Michael J Germain; Donal J O'Donoghue; Rachael L Morton; Gregorio T Obrador Journal: Kidney Int Date: 2015-04-29 Impact factor: 10.612
Authors: Joanna B Broad; Merryn Gott; Hongsoo Kim; Michal Boyd; He Chen; Martin J Connolly Journal: Int J Public Health Date: 2012-08-15 Impact factor: 3.380
Authors: Vanessa Grubbs; Alvin H Moss; Lewis M Cohen; Michael J Fischer; Michael J Germain; S Vanita Jassal; Jeffrey Perl; Daniel E Weiner; Rajnish Mehrotra Journal: Clin J Am Soc Nephrol Date: 2014-08-07 Impact factor: 8.237
Authors: Anne M Murray; Cheryl Arko; Shu-Cheng Chen; David T Gilbertson; Alvin H Moss Journal: Clin J Am Soc Nephrol Date: 2006-09-06 Impact factor: 8.237
Authors: Fliss E M Murtagh; Aine Burns; Olivier Moranne; Rachael L Morton; Saraladevi Naicker Journal: Clin J Am Soc Nephrol Date: 2016-08-10 Impact factor: 8.237
Authors: Shahid M Chandna; Maria Da Silva-Gane; Catherine Marshall; Paul Warwicker; Roger N Greenwood; Ken Farrington Journal: Nephrol Dial Transplant Date: 2010-11-22 Impact factor: 5.992
Authors: Sarah Tonkin-Crine; Ikumi Okamoto; Geraldine M Leydon; Fliss E M Murtagh; Ken Farrington; Fergus Caskey; Hugh Rayner; Paul Roderick Journal: Am J Kidney Dis Date: 2014-10-08 Impact factor: 8.860
Authors: Susan P Y Wong; Saritha Boyapati; Ruth A Engelberg; Bjorg Thorsteinsdottir; Janelle S Taylor; Ann M O'Hare Journal: Am J Kidney Dis Date: 2019-09-27 Impact factor: 8.860
Authors: Susan P Y Wong; Margaret K Yu; Pamela K Green; Chuan-Fen Liu; Paul L Hebert; Ann M O'Hare Journal: Am J Kidney Dis Date: 2018-01-10 Impact factor: 8.860
Authors: Nur Raziana Binti Rozi; Wan Ahmad Syahril Rozli Wan Ali; Che Rosle Bin Draman; Hafizah Binti Pasi Journal: Indian J Palliat Care Date: 2021-02-17
Authors: Robert A Cohen; Alexandra Bursic; Emily Chan; Marie K Norman; Robert M Arnold; Jane O Schell Journal: Clin J Am Soc Nephrol Date: 2021-02-12 Impact factor: 10.614
Authors: Jake Tobin; Alice Rogers; Isaac Winterburn; Sebastian Tullie; Asanish Kalyanasundaram; Isla Kuhn; Stephen Barclay Journal: BMJ Support Palliat Care Date: 2021-02-19 Impact factor: 4.633
Authors: Shirley Chambers; Helen Healy; Wendy E Hoy; Adrian Kark; Sharad Ratanjee; Geoffrey Mitchell; Carol Douglas; Patsy Yates; Ann Bonner Journal: BMC Palliat Care Date: 2018-04-05 Impact factor: 3.234
Authors: Osasuyi Iyasere; Edwina A Brown; Lina Johansson; Andrew Davenport; Ken Farrington; Alexander P Maxwell; Helen Collinson; Stanley Fan; Ann-Marie Habib; John Stoves; Graham Woodrow Journal: Clin Kidney J Date: 2018-07-20
Authors: Paul R Duberstein; Michael Chen; Michael Hoerger; Ronald M Epstein; Laura M Perry; Sule Yilmaz; Fahad Saeed; Supriya G Mohile; Sally A Norton Journal: J Pain Symptom Manage Date: 2019-10-19 Impact factor: 3.612